Miami Breast Cancer Conference : Attendee Tumor Board Online
WebcastFaculty
OVERVIEW
Miami Breast Cancer Conference : Attendee Tumor Board Online is organized by Physicians Education Resource, LLC (PER) and will be held during Nov 30, 2017 - Nov 30, 2018.
The target audience for this medical event is directed toward medical oncologists, surgical oncologists, and radiation oncologists involved in the treatment and management of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate.
Course Description :
This Conference has radically transformed the ability of physicians and healthcare professionals to provide world-class care for their patients through engaging and practice-changing educational programming that provides up-to-the-minute advances in breast cancer oncology. It is designed to bring expert perspectives on late-breaking research findings, controversies, and other breakthroughs to our attendees. Following 35 years of such innovation and leadership, Miami Breast Cancer Conference® continues to refine and improve its approach toward breast cancer education. Supplemental activities such as these are created to provide essential updates so that practitioners can maintain state-of-the-art care for their patients year-round.
Learning Objectives :
At the conclusion of this activity, you should be better prepared to:
• Assess how recent evidence and guidelines can be applied to overall treatment planning, including loco-regional and systemic treatment considerations for patients with breast cancer.
• Describe the evolving role of molecular testing to optimize clinical decision making in breast cancer treatment settings.
• Identify patients who might benefit from participation in ongoing breast cancer clinical trials.
• Explain how disease- and patient-related factors can be used to guide breast cancer management, including proactive identification and mitigation of treatment-related toxicities.
The target audience for this medical event is directed toward medical oncologists, surgical oncologists, and radiation oncologists involved in the treatment and management of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate.
Course Description :
This Conference has radically transformed the ability of physicians and healthcare professionals to provide world-class care for their patients through engaging and practice-changing educational programming that provides up-to-the-minute advances in breast cancer oncology. It is designed to bring expert perspectives on late-breaking research findings, controversies, and other breakthroughs to our attendees. Following 35 years of such innovation and leadership, Miami Breast Cancer Conference® continues to refine and improve its approach toward breast cancer education. Supplemental activities such as these are created to provide essential updates so that practitioners can maintain state-of-the-art care for their patients year-round.
Learning Objectives :
At the conclusion of this activity, you should be better prepared to:
• Assess how recent evidence and guidelines can be applied to overall treatment planning, including loco-regional and systemic treatment considerations for patients with breast cancer.
• Describe the evolving role of molecular testing to optimize clinical decision making in breast cancer treatment settings.
• Identify patients who might benefit from participation in ongoing breast cancer clinical trials.
• Explain how disease- and patient-related factors can be used to guide breast cancer management, including proactive identification and mitigation of treatment-related toxicities.
SPECIALITIES
Oncology
Quick Links